CureVac (CVAC) Event June 08, 2022, 20:15 UTC 10 1 comments (99% Neutral) CureVac (CVAC) Announces Clinical Development Update (Form 6-K) Comment Full text
FibroGen Inc (FGEN) Event June 08, 2022, 20:06 UTC 10 1 comments (99% Neutral) FIBROGEN, INC. (FGEN) Announces Executive Departure Comment Full text
Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) Event June 08, 2022, 20:05 UTC 11 1 comments (99% Neutral) AEGLEA BIOTHERAPEUTICS, INC. (AGLE) Announces Regulatory Update Comment Full text
Stoke Therapeutics (STOK) Event June 08, 2022, 20:01 UTC 11 1 comments (99% Neutral) Stoke Therapeutics, Inc. (STOK) Files Form 8-K Comment Full text
Akero Therapeutics (AKRO) Event June 08, 2022, 13:06 UTC 11 1 comments (90% Positive) Akero Therapeutics, Inc. (AKRO) Announces Clinical Development Update Comment Full text
Prometheus Biosciences Inc (company is now a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside the United States and Canada) (RXDX) Event June 08, 2022, 13:01 UTC 9 1 comments (10% Negative) PROMETHEUS BIOSCIENCES, INC. (RXDX) Announces Clinical Trial Timeline Adjustment Comment Full text
Radius Health Inc (the company was acquired by Gurnet Point Capital (“Gurnet Point”) and Patient Square Capital (“Patient Sq (RDUS) Event June 08, 2022, 12:39 UTC 9 1 comments (99% Neutral) RADIUS HEALTH, INC. (RDUS) Announces Clinical Development Update Comment Full text
NRx Pharmaceuticals Inc (NRXP) Event June 08, 2022, 11:59 UTC 11 1 comments (99% Neutral) NRX PHARMACEUTICALS, INC. (NRXP) Files Form 8-K Comment Full text
Ocular Therapeutix Inc (OCUL) Event June 08, 2022, 11:51 UTC 11 1 comments (99% Neutral) OCULAR THERAPEUTIX, INC. (OCUL) Announces Executive Departure Comment Full text
Passage Bio Inc (PASG) Event June 08, 2022, 11:44 UTC 11 1 comments (40% Negative) PASSAGE BIO, INC. (PASG) Announces Delay in period Trials for comply Comment Full text